Your shopping cart is currently empty

CT 32228 is an inhibitor of LPAAT-β. It effectively suppresses tumor cell proliferation and has an IC50 ranging from 0.1 to 0.8 μM in various leukemia cell lines. CT 32228 induces caspase activation in DHL-4 and Ramos cells. When used in combination with Rituximab, it promotes apoptosis. In vivo studies demonstrate that CT 32228 can delay xenograft tumor growth by 50%. This compound is applicable in research related to acute leukemia.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | CT 32228 is an inhibitor of LPAAT-β. It effectively suppresses tumor cell proliferation and has an IC50 ranging from 0.1 to 0.8 μM in various leukemia cell lines. CT 32228 induces caspase activation in DHL-4 and Ramos cells. When used in combination with Rituximab, it promotes apoptosis. In vivo studies demonstrate that CT 32228 can delay xenograft tumor growth by 50%. This compound is applicable in research related to acute leukemia. |
| Molecular Weight | 390.67 |
| Formula | C16H13BrClN5 |
| Cas No. | 521064-34-6 |
| Smiles | ClC=1C=CC(=C(C1)C=2N=C(N=C(N2)NC3=CC=C(Br)C=C3)N)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.